Explore the ABBV stock forecast for 2025, 2030, 2035, 2040, 2045, 2050, and 2060. Get the latest long-term AbbVie Inc (ABBV) stock price predictions, ABBV price targets, and are AbbVie shares are a good buy or sell.
KeyTakeaways: Based on AbbVie Inc (ABBV) short-term price targets offered by 11 Wall Street experts for 12 months forecast an average price target is 186.00, the Highest price target of $200, and lows of $170. AbbVie (ABBV) has achieved a Smart Score of 9, derived from an analysis of eight unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity.
Read: STRO Stock Forecast 2025, 2030, 2040 Price Target and Prediction
Table of Contents
AbbVie Inc. Common Stock (ABBV) Company Outlook
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers a range of products for various medical conditions, including autoimmune diseases, blood cancers, migraines, eye diseases, hepatitis C, and more. AbbVie also collaborates with multiple biotech companies to develop innovative treatments. Incorporated in 2012, AbbVie is headquartered in North Chicago, Illinois.
Company Profile
| Name | AbbVie Inc. |
|---|---|
| Country | United States |
| Industry | Drug Manufacturers – General |
| Sector | Healthcare |
| Employees | 50,000 |
| CEO | Richard A. Gonzalez |
| Website | www.abbvie.com |
| Ticker Symbol (Exchange) | ABBV (NASDAQ) |
Read: VERI Stock Forecast 2025, 2030, 2040 Veritone Analyst Estimate, Price Target
AbbVie Inc (ABBV) Fundamental Analysis
| Open | 159.03 |
| Day Low | 157.76 |
| Day High | 160.04 |
| 52 week Range | 130.96-182.89 |
| Avg Vol | 5,259,377 |
| Market Cap | 281.85 B |
| Dividend | 6.20 (3.88%) |
| PEG Ratio | 2.04 |
| Earnings ESP | 0.00% |
| Most Accurate Est | 3.06 |
| Current Qtr Est | 3.06 |
| Current Yr Est | 11.26 |
| Exp Earnings Date | 7/25/24 |
| Prior Year EPS | 11.11 |
| Exp EPS Growth (3-5yr) | 6.94% |
| Forward PE | 14.18 |
Related: BNTX Stock Forecast 2025, 2030, 2040 BioNTech SE Price Prediction
AbbVie Inc (ABBV) Technical Analysis
AbbVie Inc. Common Stock (NASDAQ: ABBV) stock that has increased 4.23% in price this year. It offers a dividend of $1.55 per share with a 3.84% yield, higher than the industry average of 2.68% and the S&P 500’s 1.57%. The annualized dividend of $6.20 has grown by 4.7% from last year, averaging an 8.25% increase over the past five years. With a payout ratio of 57%, AbbVie is expected to earn $11.13 per share in 2024, showing a 0.18% growth rate. Ranked 3 (Hold) by Zacks, AbbVie presents a strong dividend play and potential earnings expansion, making it a compelling investment opportunity.
AbbVie Inc (ABBV) Historical Growth Chart by Trading View
Long-term AbbVie Inc (ABBV) Stock Price Forecast for 2025, 2030, 2035, 2040, 2045, 2050, and 2060
According to the latest long-term forecast, AbbVie Inc’s (ABBV) stock price prediction currently stands at $158.26 by the middle of 2024 and will skyrocket to $237.60 by the end of 2025, $374.00 in 2029, AbbVie shares will rise $421.00 by 2030, $509.30 by 2035, $709.00 by 2040, $1,077.10 in 2045, $1,257in 2050, and $1,837 in 2060.
| Year | Mid-Year | Year-End | Change |
|---|---|---|---|
| 2024 | $164.80 | $189.10 | +4.66% |
| 2025 | $233.20 | $237.60 | +49.66% |
| 2029 | $347.60 | $374.00 | +136.43% |
| 2030 | $396.00 | $421.00 | +166.67% |
| 2035 | $496.10 | $509.30 | +221.66% |
| 2040 | $683.24 | $709.00 | +348.32% |
| 2045 | $983.00 | $1,077.10 | +520.39% |
| 2050 | $1,150.00 | $1,257.00 | +693.86% |
| 2060 | $1,2,53.07 | $1,837.00 | +1060.17% |
More accurate stock forecast and price predictions:
- LLY Stock Forecast 2025, 2030, 2040, Price Target and Prediction
- VFS Stock Forecast 2025, 2030, 2040 Price Target and Prediction
- KO Stock Forecast 2025, 2030, 2040 Price Target and Prediction
AbbVie Inc | ABBV Stock Forecast 2024
According to our current short-term ABBV stock forecast, the value of AbbVie Inc shares will rise by 4.81% and reach $ 164.80 per share by May 30, 2024.
AbbVie Inc | ABBV Stock Forecast 2025
According to the latest stock market research by our analysts forecast, AbbVie Inc’s stock (ABBV) average price target for 2025 is currently $233.20, with a High estimate of $237.60, and a low estimated share price target is $190.50. This represents a potential upside of +49.66% from its current price.
AbbVie Inc | ABBV Stock Forecast 2029
We believe AbbVie’s stock is seen as a wise investment for the long term due to the success of its popular cancer drug Imbruvica and the promising potential of its newer immunology drugs Skyrizi and Rinvoq.
Analysts project that ABBV stock will reach a record-high price target of $347.60 to $374.60 by May 18, 2029, representing a +136.43% change from its current price.
AbbVie Inc | ABBV Stock Forecast 2030
| Year | Mid-Year | End-Year | Change |
|---|---|---|---|
| 2030 | $396.00 | $421.00 | +166.67% |
In 2030, AbbVie Inc’s (ABBV) stock is expected to trade between $396.00 and $421.00, assuming that ABBV shares will grow by +166.67% at the average yearly rate seen in the past decade.
AbbVie Inc | ABBV Stock Forecast 2035
Analysts predict the average AbbVie Inc (ABBV) share price target for 2035 to be around $496.10 to 509.30. This represents a potential upside of +221.66% from its current price.
AbbVie Inc | ABBV Stock Forecast 2040
Based on the historical growth of AbbVie Inc. over the past 10 years, AbbVie Inc. (ABBV) stock will continue its momentum and hit $709.00 in 2040. This represents a potential upside of +348.32% from its current price.
AbbVie Inc | ABBV Stock Forecast 2045
AbbVie Inc (ABBV) stock price forecast is projected to reach an average price target range of $983.00 to $1,077.10in 2045 This indicates a whopping +693.86% change from the last recorded price of $158.26.
AbbVie Inc | ABBV Stock Forecast 2050
Our stock price prediction algorithm expects Abbvie’s stock price to hit $1,257.00 in 2050. We forecast a +693.86% rise assuming that ABBV shares will grow by +166.67% at the average yearly rate seen in the past decade.
AbbVie Inc | ABBV Stock Forecast 2060
According to experts, the highest average price target for AbbVie (ABBV) stock in 2060 is $1,2,53.07, with a high of $1,837.00 and a low of $1,161.00. The current price of ABBV stock is $159.11.
What is AbbVie’s stock price worth in 2025?
Based on Long-Term Abbvie Stock Price Predictions for 2025, AbbVie Inc (ABBV) is expected to skyrocket to an average price target of $237.60. This indicates a whopping 49.66% change from the last recorded price of $158.26.
What is the Abbvie stock price prediction for 2040?
Our experts predict Abbvie’s stock price to reach 709 USD in 2040.
Abbvie’s stock price prediction for 2050 is $1,257.00
Abbvie’s stock price prediction for 2060 is $1,837.00
Ashish Dwivedi is the founder and chief editor of MoneyMystica, a top resource for finance, insurance, and share market insights. Driven by a passion for empowering individuals to make informed financial decisions, Ashish uses his extensive knowledge and practical experience to offer clear and actionable advice.
